Ing-Jun Chen Selected Research

urgosedin

9/2004

Urgosedin inhibits hypotension, hypoglycemia, and pro-inflammatory mediators induced by lipopolysaccharide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ing-Jun Chen Research Topics

Disease

8	Inflammation (Inflammations) 05/2014 - 07/2007
7	Pulmonary Hypertension 01/2017 - 03/2004
5	Vascular Remodeling 01/2017 - 11/2004
5	Right Ventricular Hypertrophy 05/2015 - 05/2010
5	Hypertension (High Blood Pressure) 06/2014 - 03/2004
5	Hypotension (Low Blood Pressure) 08/2005 - 09/2004
4	Body Weight (Weight, Body) 09/2018 - 04/2009
4	Myocardial Infarction 02/2016 - 08/2006
4	Hypertrophy 06/2015 - 06/2006
4	Necrosis 06/2011 - 08/2004
4	Heart Failure 06/2006 - 03/2004
3	Hyperlipidemias (Hyperlipidemia) 09/2018 - 08/2011
3	Left Ventricular Dysfunction 01/2017 - 06/2006
3	Pulmonary Arterial Hypertension 12/2016 - 05/2010
3	Obesity 08/2016 - 04/2009
3	Hypoxia (Hypoxemia) 06/2016 - 04/2012
3	Cardiomegaly (Heart Hypertrophy) 06/2015 - 03/2010
3	Prostatic Neoplasms (Prostate Cancer) 12/2013 - 02/2009
3	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2013 - 12/2007
3	Neuroblastoma 01/2011 - 12/2007
3	Congenital Heart Defects (Congenital Heart Defect) 06/2006 - 09/2005
2	Osteoporosis 09/2015 - 01/2013
2	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2014 - 05/2009
2	Hyperplasia 01/2014 - 09/2007
2	Intracranial Vasospasm 01/2013 - 12/2007
2	Atherosclerosis 08/2011 - 11/2004
2	Infarction (Infarctions) 01/2011 - 08/2006
2	Wounds and Injuries (Trauma) 03/2008 - 03/2007
2	Bradycardia 06/2002 - 03/2002
2	Tachycardia (Tachyarrhythmias) 06/2002 - 03/2002
1	Diabetic Nephropathies (Diabetic Nephropathy) 06/2017
1	Fatty Liver 08/2016

Drug/Important Bio-Agent (IBA)

23	KMUP 1IBA 09/2018 - 09/2007
10	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 06/2017 - 03/2004
8	XanthineIBA 09/2018 - 03/2010
8	rho-Associated KinasesIBA 01/2017 - 05/2010
6	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2017 - 01/2005
6	Proteins (Proteins, Gene)FDA Link 08/2016 - 01/2005
6	eugenosedin-AIBA 03/2014 - 01/2005
6	Adrenergic Receptors (Adrenergic Receptor)IBA 03/2014 - 03/2002
6	labedipinedilol AIBA 02/2013 - 11/2004
5	Endothelin-1 (Endothelin 1)IBA 01/2017 - 03/2004
5	San-Huang-Xie-Xin-TangIBA 04/2012 - 07/2007
4	Theophylline (Theon)FDA LinkGeneric 12/2016 - 05/2014
4	Sildenafil Citrate (Viagra)FDA Link 05/2015 - 06/2006
4	Cyclic GMP-Dependent Protein Kinases (Protein Kinase G)IBA 05/2015 - 03/2010
4	LipopolysaccharidesIBA 02/2013 - 09/2004
4	EnzymesIBA 01/2011 - 03/2007
3	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 09/2018 - 06/2014
3	chlorobenzeneIBA 12/2016 - 05/2014
3	MonocrotalineIBA 12/2016 - 05/2010
3	LipidsIBA 08/2016 - 04/2009
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2016 - 08/2004
3	CalcineurinIBA 06/2015 - 03/2010
3	Soluble Guanylyl CyclaseIBA 05/2015 - 06/2010
3	1,4-dihydropyridine (dihydropyridine)IBA 02/2013 - 03/2005
3	CalciumIBA 08/2006 - 03/2002
2	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 09/2018 - 09/2015
2	Simvastatin (Zocor)FDA LinkGeneric 01/2017 - 06/2016
2	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2017 - 03/2014
2	Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA 01/2017 - 11/2015
2	Phosphodiesterase InhibitorsIBA 08/2016 - 11/2015
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 08/2016 - 10/2009
2	Alanine Transaminase (SGPT)IBA 08/2016 - 10/2009
2	Matrix Metalloproteinases (MMPs)IBA 08/2016 - 01/2011
2	Glucose (Dextrose)FDA LinkGeneric 08/2016 - 04/2009
2	Atorvastatin (Lipitor)FDA Link 06/2016 - 06/2011
2	Caspase 3 (Caspase-3)IBA 06/2016 - 04/2012
2	NitritesIBA 06/2016 - 04/2012
2	CholesterolIBA 11/2015 - 02/2013
2	Atrial Natriuretic Factor (ANF)IBA 06/2015 - 09/2005
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 05/2015 - 01/2005
2	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 05/2015 - 06/2010
2	Protein Kinases (Protein Kinase)IBA 01/2014 - 01/2013
2	Doxazosin (Cardura)FDA LinkGeneric 01/2014 - 05/2009
2	Guanosine Monophosphate (5' Guanylic Acid)IBA 01/2014 - 11/2012
2	lercanidipineIBA 02/2013 - 01/2009
2	InterferonsIBA 02/2013 - 06/2011
2	baicalinIBA 04/2012 - 07/2007
2	Dinoprostone (PGE2)FDA Link 06/2011 - 01/2005
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 06/2011 - 01/2005
2	Neuroprotective AgentsIBA 01/2011 - 12/2007
2	Endothelins (Endothelin)IBA 11/2010 - 06/2006
2	Isoproterenol (Isoprenaline)FDA LinkGeneric 03/2010 - 06/2002
2	AndrogensIBA 05/2009 - 02/2009
2	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2009 - 08/2006
2	Calcitonin Gene-Related PeptideIBA 12/2007 - 09/2005
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 06/2007 - 01/2005
2	salicylhydroxamic acid (SHAM)IBA 06/2006 - 03/2004
2	CytokinesIBA 01/2005 - 09/2004
1	diethylstilbestrol monophosphate (PDES)IBA 09/2018
1	Oxidoreductases (Dehydrogenase)IBA 01/2017
1	Coenzyme A (CoA)IBA 01/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017
1	Phosphotransferases (Kinase)IBA 01/2017
1	Sterol Esterase (Hormone-Sensitive Lipase)IBA 08/2016
1	Interleukin-10 (Interleukin 10)IBA 08/2016
1	Lipase (Acid Lipase)FDA Link 08/2016
1	Triglycerides (Triacylglycerol)IBA 08/2016

Therapy/Procedure

5	Therapeutics 01/2017 - 09/2007